Recruiting
Phase 2

Arexvy

Sponsor:

Johns Hopkins University

Code:

NCT07050732

Conditions

Respiratory Syncytial Virus (RSV)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Arexvy (2 doses total)

Arexvy (3 doses total)

Arexvy (1 dose total)

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-12-12.